Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
Issued Date
2023-02-01
Resource Type
eISSN
20597029
Scopus ID
2-s2.0-85146617264
Pubmed ID
36696825
Journal Title
ESMO Open
Volume
8
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
ESMO Open Vol.8 No.1 (2023)
Suggested Citation
Koppikar S., Oaknin A., Babu K.G., Lorusso D., Gupta S., Wu L.Y., Rajabto W., Harano K., Hong S.H., Malik R.A., Strebel H., Aggarwal I.M., Lai C.H., Dejthevaporn T., Tangjitgamol S., Cheng W.F., Chay W.Y., Benavides D., Hashim N.M., Moon Y.W., Yunokawa M., Anggraeni T.D., Wei W., Curigliano G., Maheshwari A., Mahantshetty U., Sheshadri S., Peters S., Yoshino T., Pentheroudakis G. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open Vol.8 No.1 (2023). doi:10.1016/j.esmoop.2022.100774 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/81671
Title
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
Author(s)
Koppikar S.
Oaknin A.
Babu K.G.
Lorusso D.
Gupta S.
Wu L.Y.
Rajabto W.
Harano K.
Hong S.H.
Malik R.A.
Strebel H.
Aggarwal I.M.
Lai C.H.
Dejthevaporn T.
Tangjitgamol S.
Cheng W.F.
Chay W.Y.
Benavides D.
Hashim N.M.
Moon Y.W.
Yunokawa M.
Anggraeni T.D.
Wei W.
Curigliano G.
Maheshwari A.
Mahantshetty U.
Sheshadri S.
Peters S.
Yoshino T.
Pentheroudakis G.
Oaknin A.
Babu K.G.
Lorusso D.
Gupta S.
Wu L.Y.
Rajabto W.
Harano K.
Hong S.H.
Malik R.A.
Strebel H.
Aggarwal I.M.
Lai C.H.
Dejthevaporn T.
Tangjitgamol S.
Cheng W.F.
Chay W.Y.
Benavides D.
Hashim N.M.
Moon Y.W.
Yunokawa M.
Anggraeni T.D.
Wei W.
Curigliano G.
Maheshwari A.
Mahantshetty U.
Sheshadri S.
Peters S.
Yoshino T.
Pentheroudakis G.
Author's Affiliation
The Catholic University of Korea Seoul St. Mary's Hospital
Ramathibodi Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
Vall d‘Hebron Institut de Oncologia
Sun Yat-Sen University Cancer Center
Homi Bhabha National Institute
Lilavati Hospital & Research Centre, Mumbai
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Taiwan University Hospital
University of the Philippines Manila
University of the Philippines College of Medicine
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Cancer Institute Hospital of Japan Foundation for Cancer Research
Università Cattolica del Sacro Cuore, Campus di Roma
Chang Gung Memorial Hospital
National Cancer Centre, Singapore
Istituto Europeo di Oncologia
Università degli Studi di Milano
Universiti Malaya
Centre Hospitalier Universitaire Vaudois
Vajira Hospital
KK Women's And Children's Hospital
Bombay Hospital and Medical Research Centre
National Cancer Center Hospital East
College of Medicine, Pochon CHA University
Kidwai Memorial Institute of Oncology India
MedPark Hospital
St. John’s Medical College and Hospital
ESMO
Homi Bhabha Cancer Hospital and Research Centre
KPJ Johor Specialist Hospital
Ramathibodi Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
Vall d‘Hebron Institut de Oncologia
Sun Yat-Sen University Cancer Center
Homi Bhabha National Institute
Lilavati Hospital & Research Centre, Mumbai
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Taiwan University Hospital
University of the Philippines Manila
University of the Philippines College of Medicine
Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo
Cancer Institute Hospital of Japan Foundation for Cancer Research
Università Cattolica del Sacro Cuore, Campus di Roma
Chang Gung Memorial Hospital
National Cancer Centre, Singapore
Istituto Europeo di Oncologia
Università degli Studi di Milano
Universiti Malaya
Centre Hospitalier Universitaire Vaudois
Vajira Hospital
KK Women's And Children's Hospital
Bombay Hospital and Medical Research Centre
National Cancer Center Hospital East
College of Medicine, Pochon CHA University
Kidwai Memorial Institute of Oncology India
MedPark Hospital
St. John’s Medical College and Hospital
ESMO
Homi Bhabha Cancer Hospital and Research Centre
KPJ Johor Specialist Hospital
Other Contributor(s)
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer was published in 2022. It was therefore decided, by both the ESMO and the Indian Society of Medical and Paediatric Oncology (ISMPO), to convene a virtual meeting in July 2022 to adapt the ESMO 2022 guidelines to take into account the variations in the management of endometrial cancer in Asia. These guidelines represent the consensus opinion of a panel of Asian experts representing the oncological societies of China (CSCO), India (ISMPO), Indonesia (ISHMO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO). Voting was based on scientific evidence and was conducted independently of the current treatment practices and treatment access constraints in the different Asian countries, which were discussed when appropriate. The aim of this guideline manuscript is to provide guidance for the optimisation and harmonisation of the management of patients with endometrial cancer across the different regions of Asia, drawing on the evidence provided by Western and Asian trials whilst respecting the variations in clinical presentation, diagnostic practices including molecular profiling and disparities in access to therapeutic options, including drug approvals and reimbursement strategies.